Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease

Quentin Philippot1, Gaëtan Deslée2, Tracy L Adair-Kirk3

  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Washington University, St. Louis, Missouri, United States of America; Institut National de la Santé Et de la Recherche Medicale Unit 903, University Hospital, Reims, France.

Plos One
|May 3, 2014
PubMed

Insights

Iron accumulates in lung macrophages in chronic obstructive pulmonary disease (COPD), increasing with disease severity. This iron sequestration may protect against oxidative stress in COPD patients.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Biochemistry

Background:

  • Free iron in the lungs generates reactive oxygen species, contributing to chronic obstructive pulmonary disease (COPD) pathogenesis.
  • Iron accumulation is linked to oxidative stress in neurodegenerative diseases, but its role in COPD is less understood.

Purpose of the Study:

  • To investigate differences in lung iron content and iron-related gene expression between COPD patients and controls.
  • To determine if these changes correlate with the severity of airway obstruction in COPD.

Main Methods:

  • Analysis of explanted lung tissue and bronchoalveolar lavage (BAL) cells from COPD subjects and controls.
  • Histological quantification of iron-positive cells, primarily alveolar macrophages.
  • Real-time RT-PCR to assess the expression of iron transport (transferrin, transferrin receptor) and storage (ferritin) genes.

Main Results:

  • Alveolar macrophages were the main iron-accumulating cells in the lungs.
  • Iron deposit quantity and iron-positive macrophage percentage increased with COPD and emphysema severity.
  • Significant upregulation of transferrin and ferritin mRNA was observed in severe COPD lungs; their expression in BAL cells correlated with airway obstruction.

Conclusions:

  • Alveolar macrophages in COPD activate an iron sequestration mechanism.
  • This mechanism is likely a protective response against iron-induced oxidative stress in the context of COPD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30